190909 PR BIOCORP
Posts By: Sylvaine Dessard
BIOCORP enters exclusive negotiations with SANOFI to use their Mallya connected device with Sanofi’s integrated diabetes care platform
![](https://biocorpsys.com/wp-content/uploads/2019/07/PhotoC.jpg)
Under the terms of these exclusive negotiations, BIOCORP will get an initial payment of €4 million from SANOFI to support…
BIOCORP enters exclusive negotiations with SANOFI to use their Mallya connected device
190703 PR BIOCORP
BIOCORP announces the CE IIB approval of its Mallya device
190612 PR_BIOCORP
BIOCORP wins the 2019 Award for Growth Companies, category “Healthcare, Pharma, Biotech & Medtech“
190606 PR_BIOCORP
BIOCORP wins the 2019 Award for Growth Companies
![](https://biocorpsys.com/wp-content/uploads/2019/06/IMG_0561.jpeg)
Yesterday, BIOCORP received the Grand Prix category “Healthcare, Pharma, Biotech & Medtech”. Created in partnership with the French Ministry of…
BIOCORP will attend the ADA in SF
![](https://biocorpsys.com/wp-content/uploads/2019/06/Capture-d’écran-2019-06-03-à-14.24.21.png)
The annual meeting of the ADA (American Diabetes Association) Will take place in San Francisco from June 7 to 10…
BIOCORP participates in RDD in Lisbon
![](https://biocorpsys.com/wp-content/uploads/2019/05/RDD-SALON.png)
BIOCORP exhibits its connected device, Inspair, during RDD in Lisbon Respiratory Drug Delivery summit is one of the largest and…
BIOCORP exhibits its connected device, InspairTM, during RDD in Lisbon
190507 PR_BIOCORP_RDD
Letter to shareholders
LETTER-BIOCORP-EN